Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Cresci

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Pharmacogenetics and Genomics|February 11, 2010
Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromesAmber L Beitelshees, Brian N Finck, Teresa C Leone, et al.
Circulation|June 20, 2024
<i>CYP2C19</i> Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart AssociationNaveen L Pereira, Sharon Cresci, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Genetics|March 5, 2011
Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery diseaseYan Gong, Amber L Beitelshees, Rhonda M Cooper-DeHoff, et al.
Plos One|December 21, 2010
Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific mannerAmber L Beitelshees, Julie A Johnson, Megan L Hames, et al.
Pharmacogenomics|October 16, 2008
Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromesSharon Cresci, Philip G Jones, Carmen C Sucharov, et al.
Basic Research in Cardiology|August 12, 2018
A novel genetic marker of decreased inflammation and improved survival after acute myocardial infarctionEdward D Coverstone, Richard G Bach, LiShiun Chen, et al.
Journal of the American Heart Association|October 12, 2021
Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic CardiomyopathyMark V Sherrid, Daniel G Swistel, Iacopo Olivotto, et al.
Circulation|November 4, 2024
Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCMSuzanne V Arnold, Kensey L Gosch, Chantal Dolan, et al.
Circulation. Cardiovascular Genetics|February 4, 2010
Common variants in HSPB7 and FRMD4B associated with advanced heart failureThomas P Cappola, Mingyao Li, Jing He, et al.
Nature Medicine|April 22, 2008
A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failureStephen B Liggett, Sharon Cresci, Reagan J Kelly, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Pharmacogenetics and Genomics|February 11, 2010
Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromesAmber L Beitelshees, Brian N Finck, Teresa C Leone, et al.
Circulation|June 20, 2024
<i>CYP2C19</i> Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart AssociationNaveen L Pereira, Sharon Cresci, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Genetics|March 5, 2011
Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery diseaseYan Gong, Amber L Beitelshees, Rhonda M Cooper-DeHoff, et al.
Plos One|December 21, 2010
Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific mannerAmber L Beitelshees, Julie A Johnson, Megan L Hames, et al.
Pharmacogenomics|October 16, 2008
Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromesSharon Cresci, Philip G Jones, Carmen C Sucharov, et al.
Basic Research in Cardiology|August 12, 2018
A novel genetic marker of decreased inflammation and improved survival after acute myocardial infarctionEdward D Coverstone, Richard G Bach, LiShiun Chen, et al.
Journal of the American Heart Association|October 12, 2021
Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic CardiomyopathyMark V Sherrid, Daniel G Swistel, Iacopo Olivotto, et al.
Circulation|November 4, 2024
Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCMSuzanne V Arnold, Kensey L Gosch, Chantal Dolan, et al.
Circulation. Cardiovascular Genetics|February 4, 2010
Common variants in HSPB7 and FRMD4B associated with advanced heart failureThomas P Cappola, Mingyao Li, Jing He, et al.
Nature Medicine|April 22, 2008
A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failureStephen B Liggett, Sharon Cresci, Reagan J Kelly, et al.
Pageof 8